Pharma Strategies For Optimizing Returns On In-Line Products: A New Tactic For Growth
As pharma products experience intensifying margin pressure, every prescription counts. More successful pharmaceutical companies are adopting analytical techniques to identify and capture precious points of profitable market share. Learn from three examples how CPG-like behavioral analysis resulted in real top-line impact.
You may also be interested in...
Sue Nabi’s success at L’Oreal, where she headed the firm’s global L’Oreal Paris and Lancome businesses, her skin-care savvy as founder of the luxury, “clean, green and vegan” Orveda, and her experience as a career champion of diversity were major draws for Coty, where she begins as CEO on 1 September.
Chief executive Eric Hobbs talks about the technology needed to accelerate antibody, cell therapy and synthetic biology, and prepare for the next pandemic.
A recent segment of CBS News “60 Minutes” discussing potential health benefits from probiotics was highly criticized by groups including the Consumer Healthcare Products Association, the Council for Responsible Nutrition, the Natural Products Association and the International Probiotics Association.